Results 21 to 30 of about 9,945 (164)

Imaging-guided interventions modulating portal venous flow: Evidence and controversies [PDF]

open access: yes, 2022
Portal hypertension is defined by an increase in the portosystemic venous gradient. In most cases, increased resistance to portal blood flow is the initial cause of elevated portal pressure.
Cannella R.   +6 more
core   +1 more source

[The transjugular intrahepatic portosystemic shunt].

open access: yesActa medica portuguesa, 1994
The case of a 66-year-old woman with several episodes of hemorrhage by esophageal varices and ascites due to portal hypertension is presented. Despite 4 sessions of endoscopic sclerotherapy bleeding recurred. A transjugular intrahepatic portosystemic shunt was performed.
F C Leal   +7 more
openaire   +3 more sources

Volumetric Blood Flow in Transjugular Intrahepatic Portosystemic Shunt Revision Using 3‐Dimensional Doppler Sonography [PDF]

open access: yes, 2015
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/135560/1/jum2015342257 ...
Fowlkes, J. Brian   +6 more
core   +1 more source

Transjugular intrahepatic portosystemic stent-shunts: a new option in portal hypertension. [PDF]

open access: yes, 2020
These guidelines on transjugular intrahepatic portosystemic stent-shunt (TIPSS) in the management of portal hypertension have been commissioned by the Clinical Services and Standards Committee (CSSC) of the British Society of Gastroenterology (BSG) under
Armstrong, Matthew J   +14 more
core   +3 more sources

Aszites, Pfortaderthrombose und hepatische Enzephalopathie bei Leberzirrhose: Aktuelle Therapieempfehlungen [PDF]

open access: yes, 2012
Treatment of Ascites, Portal Vein Thrombosis and Hepatic Encephalopathy in Patients with Cirrhosis of the Liver Background: Ascites, portal vein thrombosis and hepatic encephalopathy are important complications of cirrhosis of the liver.
Abecasis R   +46 more
core   +1 more source

Retrospective Study of Transjugular Intrahepatic Portosystemic Shunt Placement for Cirrhotic Portal Hypertension [PDF]

open access: yes, 2020
Background and Aims: Transjugular intrahepatic portosystemic shunt (TIPS) is used for decompressing clinically significant portal hypertension. The aims of this study were to evaluate clinical outcomes and adverse events associated with this procedure ...
Bilhim, Tiago   +6 more
core   +1 more source

Role of TIPS in Improving Survival of Patients with Decompensated Liver Disease [PDF]

open access: yes, 2011
Liver cirrhosis is associated with higher morbidity and reduced survival with appearance of portal hypertension and resultant decompensation. Portal decompression plays a key role in improving survival in these patients.
Amarapurkar, Deepak N.   +1 more
core   +3 more sources

New indications for TIPSs: what do we know so far? [PDF]

open access: yes, 2023
Since 1988, transjugular intrahepatic portosystemic shunt (TIPS) has been an effective therapy for portal hyper tension in many settings. Thanks to continuous technical improvements and a wiser selection of patients, excel lent results have been achieved
De Felice I.   +5 more
core   +1 more source

Non-pharmacological Treatment of Ascites [PDF]

open access: yes, 2017
Diuretics are considered the first-line pharmacological treatment option for ascites. Diuretic treatment begins with spironolactone and furosemide.
Abaalkhail, Faisal   +4 more
core   +2 more sources

Transjugular intrahepatic portosystemic shunt (TIPS) in Spain. Clinical-epidemiological considerations in relation to a multicenter registry [PDF]

open access: yes, 2020
Objective: this study aimed to determine the epidemiological, technical and clinical data of transjugular intrahepatic portosystemic shunt (TIPS) performed by Interventional Radiology departments in Spain.
De Gregorio , Miguel Ángel   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy